Keep 340B pricing with the entities that are actually eligible.
iContracts re-verifies every customer buying at PHS prices against HRSA records every quarter and surfaces weak or conflicting matches for your team to review.
~100B
in 340B purchases in 2025, up from $66.3B in 2023
63%
of HRSA entity audits in FY2023 had adverse findings
The fastest-growing channel is also the hardest to keep eligible.
Covered entities, child sites and contract pharmacies change constantly in HRSA’s registry, not in your system. When your customer master falls behind, PHS pricing keeps flowing to entities that are no longer eligible, and the error carries into your AMP.
How iContracts solves it.
The challenge
How iContracts handles it
Eligibility lives outside your system and keeps moving.
Quarterly validation cycle. Every customer buying at PHS prices is re-verified against HRSA records each quarter, not once at setup.
Names, IDs and addresses don’t line up.
Four-point identity match: 340B ID where present, entity name, street address and ZIP code.
Partial data makes matches uncertain.
A clear result, not a guess. Each record returns an eligibility confirmation, checked against the invoice date on the sales transaction, along with the entity’s HRSA status. Weak matches and rejections are flagged for review.
Every company has a different risk appetite.
You set the posture. Choose a conservative or liberal review standard before the cycle runs.
Findings get lost in email and spreadsheets.
Review and finalize in the system. Agree, disagree or annotate each finding, then export the result for the record.
340B sales can distort AMP.
What we validate
- 340B ID where present
- Entity name match
- Street address match
- ZIP code match
- HRSA eligibility
- Active status with no termination date
- Eligibility as of the invoice date on each sales transaction
The value
- A 340B customer master proven every quarter, instead of drifting for a year
- Weak matches and rejections flagged for a person to decide, not silently accepted
- PHS pricing stays with eligible entities
- Protected government pricing, with 340B transactions correctly excluded from AMP
Let our analysts run the quarterly cycle for you.
Short on time or 340B expertise? iContracts managed services analysts run the validation every quarter, recheck exceptions by hand, and keep your PHS contracts current, so only eligible entities keep access to PHS pricing.
How it works
After each quarter closes, your iContracts analyst runs the PHS validation and confirms your eligibility settings before the cycle runs.
Every rejection is manually re-verified against HRSA records, and the quarterly findings are updated.
A detailed analysis report for your team and an executive summary for leadership.
Ineligible entities are end-dated on active PHS contracts and lose access to PHS pricing unless and until their eligibility returns.
Your analyst schedules time to review the package and answer open questions, as needed.